N.M. Stat. § 13-7-12
Coverage for orally administered anticancer medications;
limits on patient costs.
A. Group health coverage, including any form of self-insurance, offered, issued or
renewed under the Health Care Purchasing Act that provides coverage for cancer
treatment shall provide coverage for a prescribed, orally administered anticancer
medication that is used to kill or slow the growth of cancerous cells on a basis no less
favorable than intravenously administered or injected cancer medications that are
covered as medical benefits by the plan.
B. A group health plan shall not increase patient cost-sharing for anticancer
medications in order to achieve compliance with the provisions of this section.
C. Coverage of orally administered anticancer medication shall not be subject to any
prior authorization, dollar limit, copayment, deductible or coinsurance provision that
does not apply to intravenously administered or injected anticancer medication used to
kill or slow the growth of cancerous cells.